Who owns Aura Biosciences, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of AURA from SEC Form 13F filings across 146 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 146 institutions disclosed 95.4M shares of Aura Biosciences, Inc. worth $677.2M — about 100.6% of shares outstanding; the largest disclosed holder is TCG Crossover Management, LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
146
13F holders
$677.2M
value, 2026 filers
100.6%
of shares outstanding (95.4M sh)
36
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of AURA's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | TCG Crossover Management, LLCNEW | 9.5M | $67.7M | 1.6% | 10% | new |
| 2 | MONTANOVA CAPITAL, LLC | 7.2M | $51.2M | 0.9% | 7.6% | +64.8% |
| 3 | Frazier Life Sciences Management, L.P. | 7.1M | $50.4M | 1.1% | 7.5% | +39.2% |
| 4 | Long Focus Capital Management, LLC | 5.1M | $36.3M | 0.9% | 5.4% | +10.8% |
| 5 | BlackRock, Inc. | 4.7M | $33.4M | 0.0% | 5% | +31.3% |
| 6 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 4.6M | $32.9M | 0.0% | 4.9% | -4.9% |
| 7 | Caligan Partners LP | 4.3M | $30.5M | 1.4% | 4.5% | +1769.9% |
| 8 | VANGUARD CAPITAL MANAGEMENT LLC | 4.1M | $29.1M | 0.0% | 4.3% | +82.7% |
| 9 | FCPM III SERVICES B.V.NEW | 4.1M | $28.8M | 3.8% | 4.3% | new |
| 10 | ORBIMED ADVISORS LLCNEW | 3.3M | $23.7M | 0.4% | 3.5% | new |
| 11 | Medicxi Ventures Management (Jersey) Ltd | 3.0M | $21.6M | 12.2% | 3.2% | 0.0% |
| 12 | Nantahala Capital Management, LLC | 3.0M | $21.0M | 0.7% | 3.1% | +39.4% |
| 13 | Jupiter Topco LLCNEW | 2.5M | $17.8M | 0.0% | 2.6% | new |
| 14 | RA CAPITAL MANAGEMENT, L.P.NEW | 2.5M | $17.8M | 0.2% | 2.6% | new |
| 15 | Balyasny Asset Management L.P. | 2.4M | $16.7M | 0.0% | 2.5% | +322.2% |
| 16 | FRANKLIN RESOURCES INC | 2.1M | $14.7M | 0.0% | 2.2% | 0.0% |
| 17 | GEODE CAPITAL MANAGEMENT, LLC | 1.8M | $12.5M | 0.0% | 1.8% | +33.9% |
| 18 | EcoR1 Capital, LLCNEW | 1.7M | $11.8M | 0.6% | 1.8% | new |
| 19 | Redmile Group, LLCNEW | 1.7M | $11.8M | 0.8% | 1.8% | new |
| 20 | Trails Edge Capital Partners, LPNEW | 1.4M | $10.2M | 1.6% | 1.5% | new |
| 21 | Foresite Capital Management VI LLCNEW | 1.3M | $9.5M | 1.5% | 1.4% | new |
| 22 | STATE STREET CORP | 1.2M | $8.7M | 0.0% | 1.3% | +26.8% |
| 23 | Woodline Partners LPNEW | 1.2M | $8.6M | 0.0% | 1.3% | new |
| 24 | Bellevue Group AGNEW | 1.2M | $8.3M | 0.2% | 1.2% | new |
| 25 | Vivo Capital, LLCNEW | 1.2M | $8.3M | 0.8% | 1.2% | new |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.